What is EDGE ONE?

EDGE ONE uses a 10,600 nm CO₂ wavelength, absorbed strongly by water in tissue, to produce controlled ablative effects. In Fractional mode, it creates separated microthermal treatment zones while leaving intervening tissue untreated, supporting resurfacing and a healing response associated with collagen remodeling.

image-edge-one.webp

Surgical mode is intended for more localized laser ablation. The choice of pulse settings, scan geometry and treatment coverage allows practitioners to manage precision and thermal effects according to the procedure.

Key Benefits

  • Fractional resurfacing

    Improve surface irregularities while inducing a remodeling response.

  • Scar-focused protocols.

    Address selected acne scars and other suitable textural scars.

  • Wrinkle refinement.

    Reduce the appearance of fine lines and photoaging-related texture.

  • Stretch-mark improvement.

    Support resurfacing of selected textural stretch marks.

  • Surgical precision mode.

    Ablate suitable benign lesions after appropriate diagnosis.

  • Customizable scanning.

    Adapt treatment shape, coverage and settings to anatomical requirements.

  • Two modes, one platform.

    Bridge aesthetic resurfacing and selected dermatological procedures.

  • Clinical control.

    Tailor procedure intensity with an explicit plan for downtime and aftercare.

  • Technical Overview

    Technology: Fractional CO₂ laser 

    Wavelength: 10,600 nm 

    Modes: Fractional and Surgical 

    Adjustable parameters: Pulse characteristics, scan geometry and treatment coverage 

    Applications: Resurfacing, wrinkles, acne scars, selected stretch marks, benign skin lesion ablation 

    Treatment areas: Face, neck and appropriate body areas 

    Recovery: Depends on ablation depth, coverage, patient factors and protocol 

    EDGE ONE provides an intentional combination of versatility and precision: controlled resurfacing for skin-quality concerns, with dedicated capabilities for selected minor lesion procedures. 

    About Jeisys

    Founded in 2001, Jeisys Medical Inc. is a South Korean medical technology company headquartered in Seoul, specializing in the development and manufacturing of advanced energy-based aesthetic devices. With more than two decades of expertise in medical aesthetics, its portfolio spans radiofrequency (RF), high-intensity focused ultrasound (HIFU), and laser technologies. Combining Korean engineering excellence with continuous innovation, Jeisys equips aesthetic professionals worldwide with sophisticated solutions for skin rejuvenation, tightening, lifting, and body contouring, supporting personalized treatments and optimal clinical outcomes.

    Medica Group